"Bronchodilator Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Agents that cause an increase in the expansion of a bronchus or bronchial tubes.
| Descriptor ID |
D001993
|
| MeSH Number(s) |
D27.505.696.663.050.110 D27.505.954.796.050.100
|
| Concept/Terms |
Bronchodilator Agents- Bronchodilator Agents
- Agents, Bronchodilator
- Bronchial-Dilating Agents
- Agents, Bronchial-Dilating
- Bronchial Dilating Agents
- Bronchodilators
Broncholytic Effect- Broncholytic Effect
- Effect, Broncholytic
- Broncholytic Effects
- Effects, Broncholytic
Bronchodilator Effect- Bronchodilator Effect
- Effect, Bronchodilator
- Bronchodilator Effects
- Effects, Bronchodilator
|
Below are MeSH descriptors whose meaning is more general than "Bronchodilator Agents".
Below are MeSH descriptors whose meaning is more specific than "Bronchodilator Agents".
This graph shows the total number of publications written about "Bronchodilator Agents" by people in this website by year, and whether "Bronchodilator Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 2 | 0 | 2 |
| 1997 | 0 | 1 | 1 |
| 1998 | 0 | 1 | 1 |
| 1999 | 0 | 1 | 1 |
| 2001 | 1 | 0 | 1 |
| 2002 | 1 | 1 | 2 |
| 2003 | 1 | 0 | 1 |
| 2005 | 5 | 3 | 8 |
| 2006 | 3 | 0 | 3 |
| 2007 | 7 | 1 | 8 |
| 2008 | 6 | 2 | 8 |
| 2009 | 3 | 1 | 4 |
| 2010 | 3 | 0 | 3 |
| 2011 | 6 | 6 | 12 |
| 2012 | 4 | 1 | 5 |
| 2013 | 3 | 5 | 8 |
| 2014 | 2 | 3 | 5 |
| 2015 | 1 | 4 | 5 |
| 2016 | 1 | 2 | 3 |
| 2017 | 4 | 2 | 6 |
| 2018 | 8 | 1 | 9 |
| 2019 | 4 | 3 | 7 |
| 2020 | 1 | 2 | 3 |
| 2021 | 2 | 2 | 4 |
| 2022 | 1 | 5 | 6 |
| 2023 | 2 | 7 | 9 |
| 2024 | 1 | 1 | 2 |
| 2025 | 1 | 1 | 2 |
| 2026 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Bronchodilator Agents" by people in Profiles.
-
Adding tiotropium or long-acting ?2-agonists to inhaled corticosteroids: Asthma-related exacerbation risk and healthcare resource utilization. Allergy Asthma Proc. 2023 11 13; 44(6):413-421.
-
EMS Administration of Systemic Corticosteroids to Pediatric Asthma Patients: An Analysis by Severity and Transport Interval. Prehosp Emerg Care. 2023; 27(7):900-907.
-
Asthma Care Protocol Implementation in the Pediatric Intensive Care Unit. Crit Care Nurs Clin North Am. 2023 Sep; 35(3):337-346.
-
Single-inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol versus dual therapy in current and former smokers with COPD: IMPACT trial post hoc analysis. Respir Med. 2022 12; 205:107040.
-
Revisiting Mild Asthma: Current Knowledge and Future Needs. Chest. 2022 01; 161(1):26-39.
-
Treating Asthma Symptoms with Quick Relief Bronchodilators: Prescription or Over-The-Counter Inhalers. Am J Respir Crit Care Med. 2019 02 15; 199(4):P7-P8.
-
COPD Management in the Primary Care Setting. J Fam Pract. 2018 10; 67(10 Suppl):S27-S32.
-
New developments in optimizing bronchodilator treatment of COPD: a focus on glycopyrrolate/formoterol combination formulated by co-suspension delivery technology. Int J Chron Obstruct Pulmon Dis. 2018; 13:2805-2819.
-
Results of a Patient Survey Regarding COPD Knowledge, Treatment Experiences, and Practices With Inhalation Devices. Respir Care. 2018 07; 63(7):833-839.
-
Long-term health-related quality-of-life and symptom response profiles with arformoterol in COPD: results from a 52-week trial. Int J Chron Obstruct Pulmon Dis. 2018; 13:499-508.